icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Seattle, Washington
March 4-7, 2019
Back grey_arrow_rt.gif
 
 
 
IBALIZUMAB: 96-WEEK DATA AND EFFICACY IN PATIENTS RESISTANT TO COMMON ANTIRETROVIRALS
 
 
  Reported by Jules Levin
CROI 2019 March 4-7 Seattle
 
B. EMU1, J. LALEZARI2, P. KUMAR3, S.WEINHEIMER4, S. LEWIS4, B. CASH5, Z. MIAO6, Z. COHEN6
 
1Yale School of Medicine, New Haven, CT, 2Quest Clinical Research, San Francisco, CA, 3Georgetown University Medical Center, Washington, DC, 4TaiMed Biologics, Irvine, CA, 5Syneos Health, Somerset, NJ, 6Theratechnologies, Montréal, Canada

0313191

0313192

0313193

0313194

0313195